Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 March 2006

Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.

Marjana Glaser

Med Sci Monit 2006; 12(3): CR113-117 :: ID: 447108

Abstract

Background: In patients with terminal renal failure, the most frequentlynoted hematological change is normocytic normochromic anemia. As not all anemic patients respond in thesame way to treatment with human erythropoietin, the aim of our investigation was to confirm the hypothesisthat the origin of this anemia is multifactorial. Material/Methods: Therefore we cultivated peripheralblood CFU GEMM, CFU GM, and BFU E in 65 patients treated by hemodialysis, subdivided in two groups accordingto creatinine concentration (Group 1: 900 micromol/l). Hematopoietic stemcells were cultivated on methylcellulose with growth factors added. Results: Growth inhibition of BFUE and CFU GM and a negative correlation between CFU GEMM, CFU GM, and BFU E growth and urea concentrationwere found in the entire group of patients. CFU GEMM growth in Group 2 was inhibited. Positive correlationbetween CFU GM and BFU E, CFU GEMM and BFU E, and CFU GM and CFU GEMM growth was established. In Group1 a negative correlation between BFU E and CFU GM growth and creatinine concentration was found, andin Group 2 a negative correlation between BFU E and CFU GM growth and urea concentration. Conclusions:Relatively decreased erythropoietin concentration is one of the major causes of renal anemia. As CFUGM and CFU GEMM growth was decreased, hematopoiesis must be disturbed at a higher level and is affectedby other factors connected with uremia, such as the lack of T[sub]4[/sub] lymphocytes and the dialysis procedure.

Keywords: Colony-Forming Units Assay, Enzyme-Linked Immunosorbent Assay, Erythroid Precursor Cells - drug effects, Erythropoietin - pharmacology, Hematopoiesis - drug effects, Hematopoietic Cell Growth Factors - pharmacology, Hematopoietic Stem Cells - drug effects, Kidney Failure, Chronic - pathology, Renal Dialysis

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750